Lung Cancer: Chaired by Jason Porter, MD

January 26, 2021

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of lung cancer.

Lung Cancer: Chaired by Jason Porter, MD

The live filming of this virtual event in our IPC series is now on-demand.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of lung cancer.

Speakers:

  • Jason Porter, MD | West Cancer Center & Research Institute
  • Wade T. Iams, MD | Vanderbilt-Ingram Cancer Center
  • Ramakrishna Battini, MD | West Cancer Center & Research Institute
  • David C. Portnoy, MD, FACP | West Cancer Center & Research Institute

Topics:

  • Frontline SCLC
  • Second Line SCLC
  • Targeting EGFR in Lung Cancer
  • Other Targetable Alterations (RET, METex14, BRAF, HER2)
x